Healthcare Asset Due Diligence: Risks and Opportunities

Abstract

Current healthcare due diligence leaves investors with a critical blind spot: due diligence is unable to identify an intellectual property variable that determines investment outcomes. This article shows how to find that variable, discusses case studies illustrating how that variable creates or destroys value, and provides a reliable framework to assure that your due-diligence team provides guidance that is not merely correct, but effective.